Liming Lin
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
-
- Blood Pressure and Hypertension Studies
Papers in ⓘ
-
- Blood Pressure and Hypertension Studies 6
- Cardiovascular Health and Risk Factors 6
- Cardiac Fibrosis and Remodeling 4
- Cardiovascular Disease and Adiposity 4
-
- Antimicrobial Peptides and Activities 5
- Co-authors
- Guilan Quan (6 shared papers)Chao Lü (6 shared papers)Chuanbin Wu (6 shared papers)Rui Luo (5 shared papers)Dongyi Xian (4 shared papers)Jinxiu Lin (7 shared papers)Meifang Wu (5 shared papers)Xin Pan (4 shared papers)
- Journals
- International Immunopharmacology (3 papers)Acta Pharmaceutica Sinica B (2 papers)International Journal of Biological Macromolecules (2 papers)Nature Communications (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Liming Lin
62 papers receiving 830 citations
Peers
Comparison fields: 5 of 110
- Microbiology 105
- Cardiology and Cardiovascular Medicine 151
- Pharmaceutical Science 34
- Endocrinology 28
- Endocrinology, Diabetes and Metabolism 88
Countries citing papers authored by Liming Lin
This map shows the geographic impact of Liming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Lin more than expected).
Fields of papers citing papers by Liming Lin
This network shows the impact of papers produced by Liming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Lin. The network helps show where Liming Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 123 | |
| 2 | 2022 | 101 | |
| 3 | 2015 | 42 | |
| 4 | 2016 | 32 | |
| 5 | 2023 | 31 | |
| 6 | 2019 | 31 | |
| 7 | 2021 | 30 | |
| 8 | 2018 | 28 | |
| 9 | 2015 | 25 | |
| 10 | 2021 | 25 | |
| 11 | 2010 | 23 | |
| 12 | 2016 | 20 | |
| 13 | 2017 | 20 | |
| 14 | 2024 | 17 | |
| 15 | 2010 | 16 | |
| 16 | 2021 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2012 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2013 | 14 |
About Liming Lin
Liming Lin is a scholar working on Cardiology and Cardiovascular Medicine, Microbiology, Endocrinology, Diabetes and Metabolism, Endocrinology and Molecular Biology, having authored 73 papers that have together received 842 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Cardiovascular Health and Risk Factors (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Antimicrobial Peptides and Activities (5 papers), Ubiquitin and proteasome pathways (5 papers), Cardiac Fibrosis and Remodeling (4 papers), Cardiovascular Disease and Adiposity (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Microbiology (105 citations), Cardiology and Cardiovascular Medicine (151 citations), Pharmaceutical Science (34 citations), Endocrinology (28 citations) and Endocrinology, Diabetes and Metabolism (88 citations). Liming Lin has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Guilan Quan, Chao Lü, Chuanbin Wu, Rui Luo, Dongyi Xian, Jinxiu Lin, Meifang Wu, Xin Pan, Xiaoqian Feng and G. Kinard. Their work appears in journals such as International Immunopharmacology, Acta Pharmaceutica Sinica B, International Journal of Biological Macromolecules, Nature Communications and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.